PharmassêtX

PharmassêtX is a pharmaceutical development company in the late preclinical stage. The company is developing high-purity, highly effective drugs for the treatment of inflammatory bowel disease (IBD). PharmassêtX ODD is used to treat pouchitis, a rare but debilitating form of IBD that many patients who have undergone colectomy surgery develop.